Eli Bar's most recent trade in Dicks Sporting Goods, Inc. was a trade of 1,330 Common Stock, par value $0.01 per share done at an average price of $204.7 . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 204.69 per share. | 02 Jul 2025 | 1,330 | 12,465 (0%) | 0% | 204.7 | 272,238 | Common Stock, par value $0.01 per share |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.31 per share. | 02 Jul 2025 | 500 | 14,295 (0%) | 0% | 11.3 | 5,655 | Common Stock, par value $0.01 per share |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2025 | 500 | 0 | - | - | Stock Option (Right to Buy) | |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 204.54 per share. | 02 Jul 2025 | 500 | 13,795 (0%) | 0% | 204.5 | 102,270 | Common Stock, par value $0.01 per share |
| Allogene Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 95,400 | 95,400 | - | - | Restricted Stock Unit | |
| Veracyte Inc | Eliav Barr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 9,321 | 51,189 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 21,500 | 21,500 | - | - | Stock Option (Right to Buy) | |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Sale of securities on an exchange or to another person at price $ 227.79 per share. | 11 Jun 2025 | 4,682 | 17,926 (0%) | 0% | 227.8 | 1,066,513 | Class A Common Stock |
| Cambium Networks Corp | Melissa Elizabeth Cada-Bartoli | Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.32 per share. | 01 Jun 2025 | 59 | 6,547 (0%) | 0% | 0.3 | 19 | Ordinary Shares |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 May 2025 | 269 | 23,368 (0%) | 0% | 223.1 | 60,009 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 May 2025 | 183 | 23,185 (0%) | 0% | 223.1 | 40,824 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.29 per share. | 10 May 2025 | 146 | 22,929 (0%) | 0% | 214.3 | 31,286 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.29 per share. | 10 May 2025 | 110 | 23,075 (0%) | 0% | 214.3 | 23,572 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.29 per share. | 10 May 2025 | 102 | 22,608 (0%) | 0% | 214.3 | 21,858 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.30 per share. | 10 May 2025 | 88 | 22,841 (0%) | 0% | 214.3 | 18,858 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.29 per share. | 10 May 2025 | 86 | 22,755 (0%) | 0% | 214.3 | 18,429 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.29 per share. | 10 May 2025 | 45 | 22,710 (0%) | 0% | 214.3 | 9,643 | Class A Common Stock |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 184.97 per share. | 03 Apr 2025 | 1,863 | 13,795 (0%) | 0% | 185.0 | 344,599 | Common Stock, par value $0.01 per share |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2025 | 1,352 | 15,658 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cambium Networks Corp | Melissa Elizabeth Cada-Bartoli | Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 28 Mar 2025 | 42 | 6,606 (0%) | 0% | 0.7 | 29 | Ordinary Shares |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 2,467 | 14,306 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 683 | 11,839 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Cambium Networks Corp | Melissa Elizabeth Cada-Bartoli | Global Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.81 per share. | 28 Feb 2025 | 59 | 6,648 (0%) | 0% | 0.8 | 48 | Ordinary Shares |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 6,355 | 25,018 (0%) | 0% | 0 | Class A Common Stock | |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 Feb 2025 | 760 | 24,258 (0%) | 0% | 223.1 | 169,541 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 Feb 2025 | 149 | 24,027 (0%) | 0% | 223.1 | 33,239 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 Feb 2025 | 103 | 23,714 (0%) | 0% | 223.1 | 22,977 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.09 per share. | 10 Feb 2025 | 82 | 24,176 (0%) | 0% | 223.1 | 18,293 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 Feb 2025 | 77 | 23,637 (0%) | 0% | 223.1 | 17,177 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 Feb 2025 | 62 | 23,817 (0%) | 0% | 223.1 | 13,831 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.08 per share. | 10 Feb 2025 | 61 | 23,879 (0%) | 0% | 223.1 | 13,608 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.07 per share. | 10 Feb 2025 | 55 | 23,972 (0%) | 0% | 223.1 | 12,269 | Class A Common Stock |
| Appfolio Inc - Ordinary Sh... | Elizabeth Erin Barat | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.09 per share. | 10 Feb 2025 | 32 | 23,940 (0%) | 0% | 223.1 | 7,139 | Class A Common Stock |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 237.27 per share. | 03 Feb 2025 | 37 | 11,156 (0%) | 0% | 237.3 | 8,779 | Common Stock, par value $0.01 per share |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 96,377 | 96,377 | - | - | Restricted Stock Units | |
| Cambium Networks Corp | Melissa Elizabeth Cada-Bartoli | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 27 Dec 2024 | 34 | 4,846 (0%) | 0% | 0.9 | 29 | Ordinary Shares |
| Cambium Networks Corp | Melissa Elizabeth Cada-Bartoli | See Remarks | Sale of securities on an exchange or to another person at price $ 1.24 per share. | 02 Dec 2024 | 50 | 4,880 (0%) | 0% | 1.2 | 62 | Ordinary Shares |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.12 per share. | 03 Sep 2024 | 8 | 11,193 (0%) | 0% | 232.1 | 1,857 | Common Stock, par value $0.01 per share |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Aug 2024 | 4,000 | 0 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Aug 2024 | 4,000 | 61,472 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Eliav Barr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,473 | 41,868 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 191,082 | 191,082 | - | - | Stock Option (Right to buy) | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 3,968 | 57,345 (0%) | 0% | 0 | Common Stock | |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2024 | 1,011 | 12,062 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 211.19 per share. | 03 Apr 2024 | 861 | 11,201 (0%) | 0% | 211.2 | 181,835 | Common Stock, par value $0.01 per share |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.31 per share. | 22 Mar 2024 | 2,175 | 13,226 (0%) | 0% | 11.3 | 24,599 | Common Stock, par value $0.01 per share |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2024 | 2,175 | 500 | - | - | Stock Option (Right to Buy) | |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Sale of securities on an exchange or to another person at price $ 221.78 per share. | 22 Mar 2024 | 2,175 | 11,051 (0%) | 0% | 221.8 | 482,372 | Common Stock, par value $0.01 per share |
| Dicks Sporting Goods, Inc. | Elizabeth H. Baran | SVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 337 | 11,051 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 1,033 | 53,255 (0%) | 0% | 0 | Common Stock | |
| Dicks Sporting Goods, Inc. | Baran Elizabeth H. | SVP - General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2024 | 995 | 10,714 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| UroGen Pharma Ltd | Barrett Elizabeth | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 87,615 | 87,615 | - | - | Restricted Stock Units | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2023 | 113,499 | 233,674 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2023 | 15,140 | 36,990 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Purchase of securities on an exchange or from another person at price $ 20.94 per share. | 01 Nov 2023 | 1,909 | 51,969 (0%) | 0% | 20.9 | 39,965 | Common Stock |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Purchase of securities on an exchange or from another person at price $ 18.64 per share. | 09 Aug 2023 | 2,000 | 3,000 (0%) | 0% | 18.6 | 37,279 | Common Stock |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 116,120 | 116,120 | - | - | Stock Option (Right to Buy) | |
| Veracyte Inc | Eliav Barr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 9,674 | 30,395 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 973 | 49,642 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 May 2023 | 200 | 2,103 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Purchase of securities on an exchange or from another person at price $ 50.50 per share. | 09 May 2023 | 1,000 | 1,000 (0%) | 0% | 50.5 | 50,500 | Common Stock |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Feb 2023 | 89,130 | 89,130 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 2,359 | 48,513 (0%) | 0% | 0 | Common Stock | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 100,000 | 100,000 | - | - | Performance Stock Units | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 13,333 | 13,334 | - | - | Restricted Stock Units | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 13,333 | 326,691 (1%) | 0% | - | Ordinary Shares | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 5,000 | 0 | - | - | Restricted Stock Units | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 5,000 | 313,358 (1%) | 0% | - | Ordinary Shares | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Purchase of securities on an exchange or from another person at price $ 38.00 per share. | 07 Nov 2022 | 3,330 | 45,975 (0%) | 0% | 38 | 126,540 | Common Stock |
| Veracyte Inc | Eliav Barr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 20,721 | 20,721 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 9,947 | 9,947 | - | - | Stock Option (Right to Buy) | |
| Allogene Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 71,070 | 71,070 | - | - | Stock Option (Right to Buy) | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 May 2022 | 750 | 1,871 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 26 May 2022 | 200 | 2,108 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 2,314 | 42,110 (0%) | 0% | 0 | Common Stock | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 13,333 | 26,667 | - | - | Restricted Stock Units | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 13,333 | 314,318 (1%) | 0% | - | Ordinary Shares | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 31 Jan 2022 | 5,960 | 308,358 (1%) | 0% | 7.6 | 45,177 | Ordinary Shares |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 5,000 | 303,220 (1%) | 0% | - | Ordinary Shares | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 31 Jan 2022 | 2,235 | 300,985 (1%) | 0% | 7.6 | 16,941 | Ordinary Shares |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 2,048 | 2,048 | - | - | Stock Options (Right to buy) | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 105,689 | 0 | - | - | Restricted Stock Units | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 105,689 | 345,188 (1%) | 0% | - | Ordinary Shares | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.15 per share. | 03 Jan 2022 | 46,968 | 298,220 (1%) | 0% | 9.1 | 429,757 | Ordinary Shares |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Nov 2021 | 154,300 | 154,300 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Nov 2021 | 146,900 | 146,900 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Nov 2021 | 45,000 | 45,000 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Sep 2021 | 4,000 | 4,000 (0%) | 0% | 0 | Common Stock | |
| Allogene Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 63,385 | 63,385 | - | - | Stock Option (Right to Buy) | |
| Sage Therapeutics Inc | Elizabeth Barrett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 May 2021 | 500 | 1,106 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 May 2021 | 500 | 1,882 (0%) | 0% | 0 | Common Stock | |
| Barnes Group Inc. | Elijah K. Barnes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 2,004 | 39,309 (0%) | 0% | 0 | Common Stock | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2021 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| UroGen Pharma Ltd | Elizabeth Barrett | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2021 | 40,000 | 40,000 | - | - | Restricted Stock Units |